Terumo (TYO:4543) is reportedly eyeing a nearly $1.5 billion deal for Abbott‘s (NYSE:ABT) cardiovascular device business. The ¥150 billion deal, if consummated, would be part of Abbott’s move to shed assets and consolidate pending the close of its $25 billion merger with St. Jude Medical (NYSE:STJ), according to Japan’s Nikkei business journal. Earlier this month, Abbott announced plans […]
Terumo
Terumo, CytoSorbents ink cardiac surgery deal
Terumo Corp. (TYO:4543) said today it inked a strategic partnership deal with CytoSorbents to commercialize its CytoSorb blood purification adsorber for cardiac surgery applications. New Jersey-based CytoSorbents said its CytoSorb adsorber is designed to reduce excessive levels of inflammatory mediators in cardiac surgery and critically ill patients. “Our collaboration with CytoSorbents enables us to offer […]
Terumo closes $280m Sequent Medical buyout
Terumo Corp. (TYO:4543) said today that its MicroVention subsidiary closed the $280 million acquisition of Sequent Medical and its Web aneurysm embolization device. The Web implant is made of a Nitinol mesh that is delivered in a “stent-like” manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. Sequent […]
UPDATE: Cerus, Terumo land $48m in BARDA grants for anti-Zika push
Updated with comments from Terumo. Cerus (NSDQ: CERS) and Terumo Corp. (TYO:4543) won grants from a U.S. Health & Human Services Dept. agency worth a collective $48 million to study their respective devices for eliminating blood pathogens like the Zika virus. Zika, which the World Health Organization declared a global emergency in February, has been linked to microcephaly, a birth […]
Terumo buys Sequent Medical for $280m
Terumo Corp. (TYO:4543) said today it picked up Sequent Medical, developer of the Web aneurysm embolization device, for $280 million. The Web implant is made of a Nitinol mesh that is delivered in a “stent-like” manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. Sequent won […]
FDA lifts shipping restrictions on Terumo’s Michigan plant
Terumo Corp. (TYO:4543) said today it received a notice from the FDA lifting all shipping restrictions at its Ann Arbor, Mich. facility that were imposed in 2011 as part of the company’s consent decree. The step is the 2nd and final phase of the company’s work plan to remediate products manufactured at the facility to comply with […]
FDA warns Terumo over vascular sheath
The FDA last week sent a warning letter to Terumo Corp. (TYO:4543) over issues with the manufacturing and quality control of its Destination Guiding vascular sheaths. The agency warned the company over issues with the manufacturing, packing, storage and installation at the facility that produces its Destination sheaths, referencing failures around design and conformity. The […]
Terumo expands Olympus Glidewire distro deal to include endo wire
Terumo Corp. (TYO:4543) said today it’s expanding its distribution partnership with Olympus (TYO:7733) to include its Glidewire endoscopic hydrophilic coated guidewire designed for endoscopic treatment of the biliary and pancreatic systems. Olympus will be the exclusive distributor in the U.S. for Terumo’s device effective immediatley. The guidewire is designed for gastroenterological procedures as a complement to […]
Terumo BCT wins FDA nod for Trima Accel
Terumo Corp.‘s (TYO:4543) BCT subsidiary said today it won FDA 510(k) clearance for a labeling change of its Trima Accel automated blood collection system. The updated classification extends the Trima Accel’s ability to store platelets in plasma from 5 days to 7, as well as operating with updated wireless capabilities, the company said. “Collaborating with customers […]
Terumo launches peripheral stent in U.S.
Terumo (TYO:4543) said today that it launched the Misago RX self-expanding peripheral stent in the U.S. The announcement was made at the Society for Vascular Surgery’s annual meeting in Chicago. The stent is designed to treat patients with peripheral artery disease in the superficial femoral artery or proximal popliteal artery, the Tokyo-based company said. “The Misago stent […]